✦ LIBER ✦

Fas and Fas ligand expression in Alzheimer's disease

✍ Scribed by I. Ferrer; B. Puig; J. Krupinski; M. Carmona; R. Blanco

Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 344 KB
Volume: 102
Category: Article
ISSN: 0001-6322
DOI: 10.1007/s004010000325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FAS/FAS ligand expression and induction

FAS/FAS ligand expression and induction of apoptosis in chondrocytes

✍ Sanshiro Hashimoto; Morteza Setareh; Robert L. Ochs; Martin Lotz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 795 KB

Objective. To examine the expression of FasIFas ligand and the role of this ligand/receptor interaction in the regulation of apoptosis in normal human articular chondrocytes and in osteoarthritis (OA) cartilage. Methods. Normal and OA human knee cartilage and cells isolated from these tissues were

Expression of Fas and Fas ligand in cuta

Expression of Fas and Fas ligand in cutaneous B-cell lymphomas

✍ Zoi-Toli, Ourania; Meijer, Chris J. L. M.; Oudejans, Joost J.; de Vries, Els; va 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 3 views

Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i

Expression of Fas ligand in retinoblasto

Expression of Fas ligand in retinoblastoma

✍ Subramanian Krishnakumar; Mallikarjuna Kandalam; Adithi Mohan; Anita Iyer; Nalin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Fas and Fas ligand: expression and solub

Fas and Fas ligand: expression and soluble circulating levels in cutaneous malignant melanoma

✍ P. Redondo; T. Solano; B. VÁzquez; A. Bauza; M. Idoate 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

Fas and Fas ligand in human hepatocellul

Fas and Fas ligand in human hepatocellular carcinoma

✍ Tetsuo Takehara; Norio Hayashi 📂 Article 📅 2001 🏛 Springer Japan 🌐 English ⚖ 38 KB

Cholangiocarcinomas express fas ligand a

Cholangiocarcinomas express fas ligand and disable the fas receptor

✍ Florencia G. Que; Vy A. Phan; Van H. Phan; Adrianne Celli; Kenneth Batts; Nichol 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB

Cholangiocarcinoma is a highly-malignant adenocarcinoma originating from cholangiocytes. Current concepts support escape from immune surveillance using aberrant expression of Fas ligand (FasL) and dysregulation of receptor (FasR) signaling as a potential mechanism for tumor progression. Our aims wer